Indraprastha Medical Corporation Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Pat Growth 25pctResults View source PDF Explain this filing

INDRAMEDCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹419.05

prior close

₹402.15

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-5.7% vs market

Hospital peers, median of 24sector+0.2%-5.2% vs sector

On the reaction day the stock moved 5.7 pts less than Nifty Microcap 250 and 5.2 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.2

10m

-0.2

15m

+0.0

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0+0.7-5.7+0.2-5.2

Next day

-9.3+0.9-10.3+0.6-9.9

-12.3+0.6-12.8-0.2-12.1

-13.5-0.8-12.7+0.0-13.5

-14.3-0.4-14.0+0.7-15.0

-14.1+0.2-14.3+2.0-16.0

-14.5+1.4-16.0+1.3-15.8

15d

-4.1+4.2-8.3+1.0-5.1

-7.3+6.3-13.6+2.1-9.4

-9.6+11.3-20.9+8.2-17.8

-10.8+14.0-24.7+6.8-17.6

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indraprastha Medical Corporation (Apollo Hospitals Delhi) reported annual revenue of Rs. 1482.51 crore, up 9.3% from Rs. 1356.36 crore in the previous year. Net profit (PAT) grew 14% to Rs. 183.62 crore versus Rs. 160.99 crore last year. EPS improved to Rs. 20.03 from Rs. 17.56. The Board recommended a dividend of Rs. 4 per share (40%) compared to Rs. 4.50 (45%) in the prior year. Operating cash flow remained healthy at Rs. 167.44 crore. Statutory auditors issued an unmodified (clean) opinion on the financial statements.

Likely market impact

The company delivered solid 14% PAT growth with positive cash generation, which is positive for shareholders. The slight dividend reduction from 45% to 40% may mildly disappoint income-focused investors, though it reflects prudent capital management.